Decreased transcript levels of the TREM2 gene may affect microglia activation and thus diminish the processing of dead neurons, myelin, and amyloid plaques, and maybe a potential pathway for TREM1 involvement in AD progression. This evidence concerns the gene TREM2 and Alzheimer disease.